Showing results (641-650 of 2,992) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|February 24, 2015
Which patients may benefit from dose adjustment of non-vitamin K antagonist oral anticoagulants?Paul K L ChinSeminars in Thrombosis and Hemostasis|February 24, 2015
Incidence of arterial embolism in patients on treatment with old and new anticoagulants for venous thromboembolismPaolo Prandoni, Marta Milan, Sofia Barbar, et al.Seminars in Thrombosis and Hemostasis|February 24, 2015
Potency labeling of novel factor VIII and factor IX concentrates: past experience and current strategyAnthony R HubbardSeminars in Thrombosis and Hemostasis|February 16, 2015
Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulantsJob Harenberg, Shanshan Du, Sandra Krämer, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulationPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
Novel or non-vitamin K antagonist oral anticoagulants and the treatment of cancer-associated thrombosisCynthia Wu, Agnes Y Y LeeSeminars in Thrombosis and Hemostasis|March 21, 2015
Can immune thrombocytopenia be cured with medical therapy?Adam Cuker, Eline T Luning Prak, Douglas B CinesSeminars in Thrombosis and Hemostasis|April 4, 2015
Rapid evaluation of fibrinogen levels using the CG02N whole blood coagulation analyzerMineji Hayakawa, Satoshi Gando, Yuichi Ono, et al.Seminars in Thrombosis and Hemostasis|August 13, 1998
The angiogenic effect of tissue factor on tumors and woundsK Nakagawa, Y Zhang, H Tsuji, et al.Seminars in Thrombosis and Hemostasis|August 13, 1998
The influence of beta2-glycoprotein I on tissue factor activityM Ieko, T Yasukouchi, K I Sawada, et al.Pageof 300